glp-1 drugs and addiction linked to lower rates in large study of veterans | Science GLP-1 Drugs and Eating Disorders:
Description
daily dosing
[DOI] [PubMed] [Google Scholar] 81.Serrano D
Research presented at the 2025 European Association for the Study of Diabetes meeting confirmed that semaglutide users report significantly fewer obsessive thoughts about food
The March 2025 quarter saw Eli Lillys revenue surge 45% YoY driven primarily by Mounjaro and Zepbound with revenue from Mounjaro alone more than doubling YoY
Garrett Evensen, Edmund Pakhlevanyan, and April Williams of Salk
In HF, the heart loses its metabolic adaptability, which throws energy metabolism into disarray
